A new study finds fewer than 30% of FDA-cleared AI medical devices reported key safety or adverse event data before approval.
Key Details
- 1Study reviewed FDA data for AI/ML devices cleared between 1995 and July 2023.
- 2Out of 691 devices analyzed, 531 were radiology-specific.
- 3Fewer than 30% of devices shared safety or adverse event information prior to clearance.
- 4Authors call for more stringent testing and clearer regulatory standards.
- 5Lack of predefined efficacy and risk standards highlighted as a critical issue.
Why It Matters
Radiology relies heavily on AI devices, making their safety and efficacy crucial to patient care. The study urges tighter oversight and transparency, which could directly impact how radiologists incorporate AI into practice.
Source
Health Imaging
Related News
•Health Imaging
BMI Significantly Impacts AI Accuracy in CT Lung Nodule Detection
New research demonstrates that high BMI negatively impacts both human and AI performance in chest low-dose CT interpretation, highlighting dataset diversity concerns.
•AI in Healthcare
Landmark AI Mammography Trial and CMS Launches AI Prior Authorization Pilot
New large randomized trial to test AI in mammography screening, while CMS launches a multi-state pilot using AI for Medicare prior authorizations.
•AuntMinnie
AI for Breast Cancer Screening Not Cost-Effective, Study Finds
AI-assisted breast cancer screening showed minor clinical benefits over DBT alone but was not cost-effective at standard willingness-to-pay thresholds.